Gold nanorod–siRNA induces efficient in vivo gene silencing in the rat hippocampus

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Prasad PN: Introduction to Biophotonics. Wiley-Interscience, NY, USA (2004).▪▪ This book established a foundation for nanomedicine and pioneered the use of nanotechnology approaches for medical therapy.
  Google Scholar
• 2  Whitesides GM: Nanoscience, nanotechnology, and chemistry. Small1(2),172–179 (2005).
  Medline CASGoogle Scholar
• 3  Agrawal A, Min DH, Singh N et al.: Functional delivery of siRNA in mice using dendriworms. ACS Nano3(9),2495–2504 (2009).
  Medline CASGoogle Scholar
• 4  Ferrari M: Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer5(3),161–171 (2005).
  Medline CASGoogle Scholar
• 5  Bharali DJ, Klejbor I, Stachowiak EK et al.: Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc. Natl Acad. Sci. USA102(32),11539–11544 (2005).▪▪ One of the first reports that used nanoparticles as carriers for gene delivery, producing local gene augmentation in the brain.
  Medline CASGoogle Scholar
• 6  Kang H, DeLong R, Fisher MH, Juliano RL: Tat-Conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. J. Pharm. Res.22(12),2099–2106 (2005).
  Medline CASGoogle Scholar
• 7  Klejbor I, Stachowiak EK, Bharali DJ et al.: ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology. J. Neurosci. Methods165(2),230–243 (2007).
  Medline CASGoogle Scholar
• 8  Ghosh P, Han G, De M, Kim CK, Rotello VM: Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev.60(11),1307–1315 (2008).
  Medline CASGoogle Scholar
• 9  Ding H, Yong K-T, Roy I et al.: Gold nanorords coathed with multilayer polyelectrolyte as contrast agent for multimodal imaging. J. Phys. Chem. C.34(111),12552–12557 (2007).▪ Methods for coating gold nanorods for imaging and for use in biomedical applications.
  Google Scholar
• 10  Huang X, Jain PK, El-Sayed IH, El-Sayed MA: Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine2(5),681–693 (2007).
  CASGoogle Scholar
• 11  Bartlett DW, Davis ME: Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing. Biotechnol. Bioeng.97(4),909–921 (2007).
  Medline CASGoogle Scholar
• 12  Davis ME: The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm.6(3),659–668 (2009).
  Medline CASGoogle Scholar
• 13  Davis ME, Zuckerman JE, Choi CH et al.: Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature464(7291),1067–1070 (2010).▪▪ One of the first reports regarding clinical application of nanotechnology for gene silencing and for use in the therapy of human disease.
  Medline CASGoogle Scholar
• 14  Li S-D, Huang L: Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim. Biophys. Acta.1788,2259–2266 (2009).
  Medline CASGoogle Scholar
• 15  Li J, Chen Y-C, Tseng Y-C, Mozumdar S, Huang L: Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J. Control. Release142,416–421 (2010).
  Medline CASGoogle Scholar
• 16  Hauck TS, Ghazani AA, Chan WC: Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small4(1),153–159 (2008).
  Medline CASGoogle Scholar
• 17  Yong K-T, Roy I, Ding H, Bergey EJ, Prasad PN: Biocompatible near-infrared quantum dots as ultrasensitive probes for long-term in vivo imaging applications. Small5(17),1997–2004 (2009).
  Medline CASGoogle Scholar
• 18  Roy I, Stachowiak MK, Bergey EJ: Non viral gene transfection nanoparticles: Functions and applications in CNS. Nanomedicine4(2),89–97 (2008).
  Medline CASGoogle Scholar
• 19  Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD: Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small1(3),325–327 (2005).
  Medline CASGoogle Scholar
• 20  Yu C, Naksharti H, Irudayaraj J: Identity profiling of cell surface markers by multiplex gold nanorod probes. Nano Lett.7(8),2300–2306 (2007).
  Medline CASGoogle Scholar
• 21  Tan WB, Jiang S, Zhang Y: Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. Biomaterials28,1565–1571 (2007).
  Medline CASGoogle Scholar
• 22  Bonoiu AC, Mahajan SD, Ding H et al.: Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc. Natl Acad. Sci. USA106(14),5546–5550 (2009).▪▪ The first application of metallic nanoparticles as a carrier platform for gene silencer delivery in neurons in vitro; demonstration of nanoplex ability to cross the brain–blood barrier (BBB) in an in vitro BBB model system and ability to modulate proteins existent downstream in biochemical pathways.
  Medline CASGoogle Scholar
• 23  Kang B, Mackey MA, El-Sayed MA: Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J. Am. Chem. Soc.132(5),1517–1519 (2010).
  Medline CASGoogle Scholar
• 24  Yong K-T, Sahoo Y, Swihart MT, Schneeberger PM, Prasad PN: Templated synthesis of gold nanorods (NRs): the effects of cosurfactants and electrolytes on the shape and optical properties. Top. Catal.47,49–60 (2008).
  CASGoogle Scholar
• 25  Nuwer MO, Picchione KE, Bhattacharjee A: cAMP-dependent kinase does not modulate the Slack sodium-activated potassium channel. Neuropharmacology57(3),219–226 (2009).
  Medline CASGoogle Scholar
• 26  Chakravarthy KV, Bonoiu AC, Davis WG et al.: Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication. Proc. Natl Acad. Sci. USA107(22),10172–10177 (2010).
  Medline CASGoogle Scholar
• 27  Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates (Third Edition). Academic Press, NY, USA, 31 (1997).
  Google Scholar
• 28  Qiu Y, Liu Y, Wang L et al.: Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials31(30),7606–7619 (2010).
  Medline CASGoogle Scholar
• 29  Taishi P, Churchill L, Wang M et al.: TNFα siRNA reduces brain TNF and EEG δ wave activity in rats. Brain Res.1156,125–132 (2007).
  Medline CASGoogle Scholar
• 30  Ignatowski TA, Noble BK, Wright JR et al.: Neuronal-associated tumor necrosis factor (TNFα): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J. Neuroimmunol.79(1),84–90 (1997).
  Medline CASGoogle Scholar
• 31  Javier DJ, Nitin N, Levy M, Ellington A, Richards-Kortum R: Aptamer-targeted gold nanoparticles as molecular-specific contrast agents for reflectance imaging. Bioconjug. Chem.19(6),1309–1312 (2008).
  Medline CASGoogle Scholar
• 32  Hu R, Yong K-T, Roy I, Ding H, He S, Prasad PN: Metallic nanostructures as localized plasmon resonance enhanced scattering probes for multiplex dark field targeted imaging of cancer cells. J. Phys. Chem. C. Nanomater. Interfaces113(7),2676–2684 (2009).▪ This paper published by our group is the first report that used biocompatible metallic nanoparticles for biological application and also as an excellent optical imaging probe for dark-field microscopy and surface plasmon resonance technology.
  Medline CASGoogle Scholar
• 33  Yong K-T, Swihart MT, Ding H, Prasad PN: Preparation of gold nanoparticles and their applications in anisotropic nanoparticle synthesis and bioimaging. Plasmonics4(2),79–93 (2009).
  CASGoogle Scholar
• 34  Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal. Biochem.162(1),156–159 (1987).
  Medline CASGoogle Scholar
• 35  Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A: Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun.313(4),856–862 (2004).
  Medline CASGoogle Scholar
• 36  Bustin SA: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J. Mol. Endocrinol.1(29),23–39 (2002).
  Google Scholar
• 37  Fu AL, Yan XB, Sui L: Down-regulation of β1-adrenoceptors gene expression by short interfering RNA impairs the memory retrieval in the basolateral amygdala of rats. Neurosci. Lett.428(2–3),77–81 (2007).
  Medline CASGoogle Scholar
• 38  Thakker DR, Natt F, Hüsken D et al.: Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc. Natl Acad. Sci. USA.101(49),17270–17275 (2004).
  Medline CASGoogle Scholar
• 39  Pardridge WM: shRNA and siRNA delivery to the brain. Adv. Drug Deliv. Rev.59(2–3),141–152 (2007).
  Medline CASGoogle Scholar
• 40  Bjarkam CR, Pedersen M, Sørensen JC: New strategies for embedding, orientation and sectioning of small brain specimens enable direct correlation to MR-images, brain atlases, or use of unbiased stereology. J. Neurosci.108(2),153–159 (2001).
  CASGoogle Scholar
• 41  Leung RK, Whittaker PA: RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol. Ther.107(2),222–239 (2005).
  Medline CASGoogle Scholar
• 42  Thakker DR, Weatherspoon MR, Harrison J et al.: Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice. Proc. Natl Acad. Sci. USA106(11),4501–4506 (2009).
  Medline CASGoogle Scholar
• 43  Hoyer D: RNA interference for studying the molecular basis of neuropsychiatric disorders. Curr. Opin. Drug Discov. Devel.10(2),122–129 (2007).
  Medline CASGoogle Scholar
• 44  Mahairaki V, Xu L, Farah MH et al.: Targeted knock-down of neuronal nitric oxide synthase expression in basal forebrain with RNA interference. J. Neurosci.179(2),292–299 (2009).
  CASGoogle Scholar
• 45  Chen C-D, Cheng S-F, Chau L-K, Wang CRC: Sensing capability of the localized surface plasmon resonance of gold nanorods. Biosens. Bioelectron.22,926–932 (2007).
  Medline CASGoogle Scholar
• 46  Cryan JF, Holmes A: The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov.4(9),775–790 (2005).
  Medline CASGoogle Scholar